Exodus Point Capital Management, LP Tango Therapeutics, Inc. Transaction History

Exodus Point Capital Management, LP

  • $13.1 Billion
  • Q1 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 19, 2022
SELL
$3.86 - $8.01 $742,374 - $1.54 Million
-192,325 Closed
0 $0
Q1 2022

May 13, 2022
BUY
$7.01 - $10.94 $889,036 - $1.39 Million
126,824 Added 193.62%
192,325 $1.46 Million
Q4 2021

Feb 11, 2022
BUY
$9.55 - $14.29 $625,534 - $936,009
65,501 New
65,501 $717,000

Others Institutions Holding TNGX

# of Institutions
127
Shares Held
88.8M
Call Options Held
2K
Put Options Held
1.6K
View Full List

About Tango Therapeutics, Inc.

TNGX Quotes by TradingView
  • Ticker TNGX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 88,067,296
  • Market Cap $714M
  • Description
  • Tango Therapeutics, Inc., a biotechnology company, discovers and develops drugs for the treatment of cancer. Its lead program is TNG908, a synthetic lethal small molecule inhibitor of protein arginine methyltransferase 5 that is being developed as a treatment for cancers with methylthioadenosine phosphorylase deletions. The company also develops...
More about TNGX
Track This Portfolio

Track Exodus Point Capital Management, LP Portfolio

Follow Exodus Point Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Exodus Point Capital Management, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email